Myungmoon Linagliptin Duo Tablet 2.5/1000mg

Adult dose

The dosage of this medication is determined based on the maximum recommended doses of each ingredient, which are linagliptin 2.5 mg and metformin 1000 mg per day not exceeding two times daily, considering each patient's current treatment regimen, efficacy, and tolerability. This medication is administered twice daily with meals. 1. If currently not being treated with metformin: The initial dose is 2.5/500 mg taken twice daily, with 1 tablet each time, and it may be increased to 2.5/1.

This medication may cause a serious side effect known as lactic acidosis, and should not be used in patients with impaired kidney function, heart disease, or poor liver function. Additionally, patients with allergies to the ingredients in this medication, those with type 1 diabetes, those who have had an acute myocardial infarction, and pregnant or breastfeeding women should not take this medication. As there is a risk of hypoglycemia, blood sugar levels should be closely monitored, especially when taken with other hypoglycemic agents, and medication doses should be adjusted as necessary. Elderly patients with reduced kidney function or taking medications that may affect kidney function should undergo regular kidney function tests, and adjustments to the medication should be made depending on the condition. This medication may need to be temporarily discontinued in cases of acute infection, dehydration, before and after surgery, and during radiological iodine contrast examinations. If sudden abdominal pain, severe joint pain, or skin blisters occur while taking this medication, consult a doctor immediately. Gastrointestinal disturbances such as abdominal pain, diarrhea, and vomiting may occur at the beginning of treatment, but they usually improve over time. Vitamin B12 deficiency may occur, so regular monitoring of vitamin B12 levels is recommended for long-term users. Women planning to become pregnant or who are pregnant should avoid taking this medication and consider alternative treatments for blood sugar control. The safety and efficacy in children and adolescents have not been established, so it is not recommended. There has not been sufficient research on the effects of this medication on driving or operating machinery, so caution is needed. In cases of overdose, there is a risk of lactic acidosis; if symptoms appear, immediate medical treatment should be sought. This medication should be stored in a tightly sealed container to avoid moisture and should be kept out of reach of children. It is advisable not to transfer it to another container.

Serious side effects

Urticaria, angioedema, lactic acidosis, vesicular pemphigoid, pancreatitis, liver dysfunction (abnormal liver function tests, hepatitis), angina pectoris, acute myocardial infarction, cardiac arrest, congestive heart failure, unstable angina, acute myocardial infarction, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, cholelithiasis, cerebral infarction, severe joint pain accompanied by disability, elevated blood pressure and generalized edema, dyspnea, asthma attacks, acute myocardial infarction.

Mild side effects

Nasopharyngitis, hypersensitivity, decreased and deficient vitamin B12, taste disturbances, cough, decreased appetite, diarrhea, constipation, nausea, vomiting, abdominal pain, mouth ulcer formation, abnormal liver function tests, hepatitis, pruritus, erythema, rashes, severe joint pain accompanied by disability, rhabdomyolysis, increased lipase, increased amylase, hypoglycemia, headache, dizziness, drowsiness, nosebleeds, oropharyngeal pain, speech disorders, rhinorrhea, exercise-induced dyspnea.

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is also best to store the medication at room temperature, which should not be too hot or too cold, preferably between 1 and 30 degrees Celsius. This way, the efficacy of the medication can be maintained for a longer time.

Appearance

Bright pink, double-convex, oval film-coated tablets

Package unit

30 tablets (6 tablets/PTP x 5 packs)